High-dosage granulocyte colony stimulating factor treatment alters monocyte trafficking to the brain after experimental stroke

Gesa Weise, Claudia Pösel, Karoline Möller, Alexander Kranz, Nadine Didwischus, Johannes Boltze, Daniel Christoph Wagner

Abstract

Ischemic stroke elicits a prompt inflammatory response that is characterized by a well-timed recruitment of peripheral immune cells to the brain. Among these, monocytes play a particularly important, but multifaceted role and have been increasingly recognized to affect stroke outcome. Granulocyte colony stimulating factor (GCSF) is known for its immunosuppressive actions on mononuclear cells, but previous studies in the stroke field were mainly confined to its neuroprotective actions. Herein, we investigated whether GCSF affects post-stroke inflammation in a mouse model of focal brain ischemia by modulating monocyte responses. Treatment with GCSF was controlled by vehicle injection, sham surgery and naive animals. Despite a significant monocytosis, high-dosage GCSF reduced the number of brain-infiltrating monocytes/macrophages four days after stroke. Lower numbers of mononuclear phagocytes in the brain were associated with smaller cerebral edema and improved motor outcome after stroke. GCSF treatment over 72 h, but not 24 h diminished integrin expression on circulating Ly6C+ inflammatory monocytes. In vitro experiments further revealed that GCSF strongly promotes interleukin (IL)-10 secretion by activated mononuclear cells. Blockade of the IL-10 receptor partly reversed GCSF-induced downregulation of integrin surface expression. Overall, our results suggest that high-dosage GCSF mitigates monocyte infiltration after stroke, likely by attenuating integrin-mediated adhesion to the brain endothelium in an IL-10-dependent manner. Lower amounts of mononuclear cells in the brain translate to less severe brain edema and functional impairment and thus support a harmful role of Ly6C+ inflammatory monocytes in the acute stage of stroke.
Original languageEnglish
JournalBrain, Behavior, and Immunity
Volume60
Pages (from-to)15-26
Number of pages12
ISSN0889-1591
DOIs
Publication statusPublished - 01.02.2017

Fingerprint

Dive into the research topics of 'High-dosage granulocyte colony stimulating factor treatment alters monocyte trafficking to the brain after experimental stroke'. Together they form a unique fingerprint.

Cite this